A preliminary, multicenter study on the relationship between cortical damage and blood brain barrier damage in Multiple Sclerosis patients with high cortical disease activity. Correlation between [11C]-PK-11195 or [18F]-NAF PET (Positron Emission Tomography) and high field MRI (Magnetic Resonance Imaging): a synergistic effect by using a double-technique approach.

Stopped earlyPhase 2MS (type not specified)2015-001202-34

What it found

Stopped

The trial ended early for another reason (see below).

What was tested

Treatment tested

  • Na18F
  • [11C]-PK-11195

What it measured

Main measures

  • To detect the presence of cortical lesions in PET images at timepoint t=40 minutes for 18F-Na and at timepoint t=20 minutes for PK11195 . To verify if these lesions are also detected by MRI sequences

    MRI lesions

Other measures (1)

  • 1.To quantify, by using [11C]-PK11195-PET, microglial activation degree within cortical lesions and ¿MRI normal appearing grey matter¿ at t=20 minutes - To estimate the correlation of microglial activation with some demographic and clinical data (age, disease duration, disability, EDSS) 2- To quantify, by using [18F]-NaF-PET, blood brain barrier damage signs in cortical lesions at t=40 minutes - T

    Disability progressionMRI lesionsSmouldering inflammation

Who could take part

MS (type not specified)

Show the full criteria

Inclusion criteria

Inclusion: - Sex: Female and Male Exclusion: - Co-occurring of other illness that can alter PET imaging (neoplasms, infectious disease, etc)

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Primary objectives of this study are:

Loading reviews and guidelines…

History

    1. Started

      Jun 2021

    Assembled by software from public sources.